NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says ...

This lung infection study substantiates the results of the previously reported intradigital footpad infection study that: (i) ...

This week on the PBD Podcast, a current-events show hosted by Patrick Bet-David, the NewsNation personality said he’s using ...

ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, ...

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE Ameri ...

The company said that in a lethal animal model of lung infection by Influenza A/H3N2 virus, NV-387 demonstrated ...

Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations ...

A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in ...

NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 6, 2024 / NanoViricides, Inc. (NYSE Americ ...

USDA, CDC and FDA hosted a media call May 1 to detail specifics of the status of highly pathogenic avian influenza.

Clinical trial application clearances received for a Phase 1a/1b trial for ABI-5366 targeting recurrent genital herpes, and a Phase 1b trial for ...

In the post-vaccine era, rotavirus has become just another cause of acute gastroenteritis in most cases. But is there anything new in diagnosis and treatment? To Test or Not to Te ...